KDR and urinary bladder cancer: In addition, circRNA-MYLK promotes cell proliferation, migration and invasion by directly binding to miR-29a and subsequently relieves suppression for target VEGFA, which activates VEGFA/VEGFR2 signaling pathway in bladder cancer [40].